Tags: FDA


How big is symptom improvement with new constipation drug? Readers might have to strain to find out


FDA release on Intrarosa approval omits important conflict of interest


FDA release offers inadequate presentation of auto-inflammatory drug approval


FDA release on hepatitis C drug informs on harms, benefits but is light on evidence

1 5/24/2016

FDA PR release on bladder cancer drug skirts lack of long-term survival data

1 5/10/2016

FDA release on drug for treating Parkinson’s psychosis lacks some key details


FDA skims over benefits and costs of cooling cap it approved for reducing hair loss during chemo